AFRINOL Drug Patent Profile
✉ Email this page to a colleague
When do Afrinol patents expire, and when can generic versions of Afrinol launch?
Afrinol is a drug marketed by Schering Plough and is included in one NDA.
The generic ingredient in AFRINOL is pseudoephedrine sulfate. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine sulfate profile page.
Summary for AFRINOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Patent Applications: | 710 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AFRINOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AFRINOL
US Patents and Regulatory Information for AFRINOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering Plough | AFRINOL | pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018191-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |